Skip to main content

Animations

MJFF Publications

5101 - 5110 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • 2022
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Ageing-associated small RNA cargo of extracellular vesicles
    Journal Name: RNA Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15476286.2023.2234713
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Association of Cortical Gyrification With Imaging and Serum Biomarkers in Patients With Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000207410
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000207408
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abm3233
    Citation Count: 165
  • Summary Details
    OPEN
    Title: A progression analysis of motor features in Parkinson's disease based on the mapper algorithm
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1047017
    Citation Count: 2
  • Summary Details
    OPEN
    Title: In vivoreduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac445
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Substitution of PINK1 Gly411 modulates substrate receptivity and turnover
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2151294
    Citation Count: 20
  • Summary Details
    OPEN
    Title: FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2022112767
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2302720120
    Citation Count: 37
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.